These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 342530)

  • 21. [Experimental conditions for the inhibition of DNA synthesis and vaccinia virus formation by a partially purified interferon].
    Keith G; Peter R; Guir J; Kirn A
    Arch Gesamte Virusforsch; 1969; 27(1):32-43. PubMed ID: 5388891
    [No Abstract]   [Full Text] [Related]  

  • 22. [Role of an interferon in the phenomenon of interference between the vaccinia virus and fixed rabies virus].
    Vieuchange J
    C R Acad Hebd Seances Acad Sci D; 1967 Jan; 264(2):426-8. PubMed ID: 4961802
    [No Abstract]   [Full Text] [Related]  

  • 23. Selective increase in lymphocyte interferon response to vaccinia antigen after revaccination.
    Epstein LB; Stevens DA; Merigan TC
    Proc Natl Acad Sci U S A; 1972 Sep; 69(9):2632-6. PubMed ID: 4506785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans.
    Billiau A; De Somers P; Edy VG; De Clercq E; Heremans H
    Antimicrob Agents Chemother; 1979 Jul; 16(1):56-63. PubMed ID: 475375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification by electron microscopy of the maturation steps in vaccinia virus morphogenesis inhibited by the interferon-induced enzymes, protein kinase (PKR), 2-5A synthetase, and nitric oxide synthase (iNOS).
    Esteban M; Patiño C
    J Interferon Cytokine Res; 2000 Oct; 20(10):867-77. PubMed ID: 11054274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-mediated cytotoxicity during vaccinia virus revaccination in man: influence of antibodies and interferon.
    Møller-Larsen A
    Scand J Immunol; 1979; 10(6):543-8. PubMed ID: 94462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Varicella zoster virus: interferon production and comparative interferon sensitivity in human cell cultures.
    Armstrong RW; Merigan TC
    J Gen Virol; 1971 Jul; 12(1):53-4. PubMed ID: 4329449
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase I trial of a recombinant vaccinia virus encoding carcinoembryonic antigen in metastatic adenocarcinoma: comparison of intradermal versus subcutaneous administration.
    Conry RM; Khazaeli MB; Saleh MN; Allen KO; Barlow DL; Moore SE; Craig D; Arani RB; Schlom J; LoBuglio AF
    Clin Cancer Res; 1999 Sep; 5(9):2330-7. PubMed ID: 10499601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of some inhibitors on the formation of the factor of nucleocapside deproteinization in vaccinia virus].
    Zhdanov VM; Peterson OP; Kozlova IA; Mel'nikova LA; Balandin IG
    Dokl Akad Nauk SSSR; 1966 Nov; 171(2):471-2. PubMed ID: 5994933
    [No Abstract]   [Full Text] [Related]  

  • 30. Rescue of vesicular stomatitis virus from interferon-induced resistance by superinfection with vaccinia virus. II. Effect of UV-inactivated vaccinia and metabolic inhibitors.
    Thacore HR; Youngner JS
    Virology; 1973 Dec; 56(2):512-22. PubMed ID: 4357054
    [No Abstract]   [Full Text] [Related]  

  • 31. [A new clinico-pharmacological method for the evaluation of the antiviral activity of distamycin A].
    Mars G; Regoli U
    Clin Ter; 1968 Jun; 44(6):573-80. PubMed ID: 5736875
    [No Abstract]   [Full Text] [Related]  

  • 32. siRNA targeting vaccinia virus double-stranded RNA binding protein [E3L] exerts potent antiviral effects.
    Dave RS; McGettigan JP; Qureshi T; Schnell MJ; Nunnari G; Pomerantz RJ
    Virology; 2006 May; 348(2):489-97. PubMed ID: 16480752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative study of the biological properties of plasmid and natural human interferons].
    Ovchinnikov IuA; Zhdanov VM; Solov'ev VD; Novokhatskiĭ AS; Aspetov RD
    Vopr Virusol; 1983; 28(1):14-21. PubMed ID: 6189294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance of vaccinia virus to interferons: modulation of the 2-5A system in interferon-treated, vaccinia virus infected cells.
    Páez E; Esteban M
    Microbiologia; 1987 Oct; 3(3):163-78. PubMed ID: 2478164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of interferon on the dynamics of H3-thymidine incorporation and thymidine kinase induction in chick fibroblast cultures infected with vaccinia virus.
    Ghosh SN; Gifford GE
    Virology; 1965 Oct; 27(2):186-92. PubMed ID: 5840890
    [No Abstract]   [Full Text] [Related]  

  • 36. Trials of interferon in respiratory infections of man.
    Tyrrell DA
    Tex Rep Biol Med; 1977; 35():486-90. PubMed ID: 358470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on tissue specificity of interferon.
    Riley BP; Gifford GE
    J Gen Microbiol; 1967 Feb; 46(2):293-7. PubMed ID: 4291502
    [No Abstract]   [Full Text] [Related]  

  • 38. Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naïve and vaccinia-immune individuals.
    Parrino J; McCurdy LH; Larkin BD; Gordon IJ; Rucker SE; Enama ME; Koup RA; Roederer M; Bailer RT; Moodie Z; Gu L; Yan L; Graham BS;
    Vaccine; 2007 Feb; 25(8):1513-25. PubMed ID: 17126963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon induced inhibition of enveloped viruses.
    Maheshwari RK; Friedman RM
    Prog Clin Biol Res; 1985; 202():297-305. PubMed ID: 2421308
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of raphanin on the multiplication of some RNA and DNA viruses in, and interferon production by, cultured cells.
    Rosztóczy I
    Acta Microbiol Acad Sci Hung; 1968; 15(4):311-6. PubMed ID: 4306944
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.